2026 RARE Drug Development Symposium

Pitch Your Disease or Asset

Available to Global Advocacy Alliance Member Organizations

We are excited to announce that applications are now open for the “Pitch Your Disease or Asset” session at Global Genes’ RARE Drug Development Symposium (RDDS 2026).

September 9 – 11, 2026

David Rubenstein Treehouse
Harvard University
20 Western Ave, Boston, MA 02134

Submit Your Pitch

Open to all GAA Members

This is a unique opportunity for GAA member organizations to present their work to leading industry experts and investors on the main stage on September 11th.

Not a member of the Global Advocacy Alliance?

Global Advocacy Alliance (GAA) membership is a requirement to submit an application for this opportunity. To become a Global Advocacy Alliance member, click here. Membership is free for patient advocacy groups, and formal 501(c) 3 status is not required.

If you have any questions, please email [email protected]

What are we looking for

For the Main Stage – Two Patient Advocates will be chosen to present on the following:

Pitch 1 – How have you made your disease attractive to industry to start a therapeutic program?

Pitch 2 – Has your organization developed or acquired a therapy and you are looking for a strategic partner to accelerate clinical development &/or commercialization?

Following the main stage presentations, we will hold 3 interactive pitch tracks, each with 2 patient advocates presenting their work, tentatively based on the following areas:

Neurodevelopmental disorders, with/ without Epilepsy
Other Neurologic conditions, including Vision-related disorders
Metabolic & Neuromuscular conditions
Disorders of Immune or Connective Tissue Function

Disease Areas are subject to change, and additional tracks may be added based on pitch applicants.

Why you should apply

Each patient advocacy organization that is chosen to pitch their disease or asset will be asked to designate one person to present onstage at RDDS on September 11, 2026.

Each “winning” organization will receive:

One complimentary full-conference registration for the 2026 Rare Drug Development Summit

Travel reimbursement for one patient advocate of up to $800 for individuals living in the United States, and up to $1200 for individuals living outside of the United States.
The unique opportunity to gain feedback from leading industry experts and investors with deep expertise in rare disease therapeutics.